Skip to main content
SpringerLink
Log in

Neoadjuvante Radiotherapie verbessert beim resezierbaren hepatozellulären Karzinom mit Portalvenen-Tumorthrombus das Gesamtüberleben und das krankheitsfreie Intervall

Neoadjuvant radiotherapy improves overall survival and disease-free interval in resectable hepatocellular carcinoma with portal vein tumor thrombosis

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bettinger D, Pinato DJ, Schultheiss M, Sharma R, Rimassa L, Pressiani T et al (2019) Stereotactic body radiation therapy as an alternative treatment for patients with Hepatocellular carcinoma compared to sorafenib: a propensity score analysis. Liver Cancer 8(4):281–294. https://doi.org/10.1159/000490260 (Epub 2018 Jul 12)

    Article  CAS  PubMed  Google Scholar 

  2. European Association for the Study of the Liver (2019) EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69(1):182–236 (PubMed PMID: 29628281)

    Google Scholar 

  3. Le Treut YP, Hardwigsen J, Ananian P, Saisse J, Gregoire E, Richa H et al (2006) Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointest Surg 10(6):855–862 (PubMed PMID: 16769542)

    Article  Google Scholar 

  4. Shi J, Lai EC, Li N, Guo WX, Xue J, Lau WY et al (2010) Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. Ann Surg Oncol 17(8):2073–2080 (PubMed PMID: 20131013)

    Article  Google Scholar 

  5. Korean Liver Cancer Association and National Cancer Center (2019) 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the management of hepatocellular carcinoma. Gut and Liver 13(3):227–299 (PubMed PMID: 31060120. Pubmed Central PMCID: 6529163.)

    Article  Google Scholar 

  6. Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M et al (2016) Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol 65(5):938–943 (PubMed PMID: 27266618)

    Article  Google Scholar 

  7. Zhang L, Li N, Wang H, Tang Y‑F, Yu H‑M, Guo W‑X et al (2017) Portal vein tumor thrombus is more sensitive to irradiation. Int J Clin Exp Med 10(3):4486–4496

    CAS  Google Scholar 

  8. Shui Y, Yu W, Ren X, Guo Y, Xu J, Ma T et al (2018) Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis. Radiat Oncol 13(1):188 (PubMed PMID: 30253783. Pubmed Central PMCID: 6157064)

    Article  Google Scholar 

  9. Yoon SM, Ryoo BY, Lee SJ, Kim JH, Shin JH, An JH et al (2018) Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial. JAMA Oncol 4(5):661–669 (PubMed PMID: 29543938. Pubmed Central PMCID: 5885246)

    Article  Google Scholar 

  10. Lin H, Li X, Liu Y, Hu Y (2018) Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma. ANZ Journal of Surgery 88(10):E718–E24 (PubMed PMID: 29399938)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University Medical Center Magdeburg, Magdeburg, Deutschland

    Thomas B. Brunner

  2. Department of General and Visceral Surgery, University Medical Center Magdeburg, Magdeburg, Deutschland

    Roland S. Croner

Authors
  1. Thomas B. Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roland S. Croner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Thomas B. Brunner or Roland S. Croner.

Ethics declarations

Interessenkonflikt

T.B. Brunner und R.S. Croner geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation

Wei X, Jiang Y, Zhang X et al (2019) Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study. J Clin Oncol 37(24): 2141–2151. https://doi.org/10.1200/JCO.18.02184PMCID: PMC6698917

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brunner, T.B., Croner, R.S. Neoadjuvante Radiotherapie verbessert beim resezierbaren hepatozellulären Karzinom mit Portalvenen-Tumorthrombus das Gesamtüberleben und das krankheitsfreie Intervall. Strahlenther Onkol 196, 194–196 (2020). https://doi.org/10.1007/s00066-019-01570-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-019-01570-2

Search

Navigation